Federal contract award
N0042121C0002
BUILT-IN ADAPTIVE SYSTEM TESTING (BAST)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NAVAL AIR WARFARE CENTER AIR DIV |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $4.3M |
| Current contract value | $4.3M |
| Potential contract value / ceiling | $4.3M |
| Start date | Jan 11, 2021 |
| Current end date | Sep 6, 2026 |
| Potential end date | Sep 6, 2026 |
| Latest award activity | May 29, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 17 of 17 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 29, 2026 | P00016 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM JUNE 6, 2026 TO SEPTEMBER 6, 2026 AT NO ADDITIONAL COST TO THE GOVERNMENT. ADMINISTRATIVELY THE FAR CLAUSE 52.222-90 IS INCORPORATED INTO THE CONTRACT. |
| Mar 6, 2026 | P00015 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM MARCH 9, 2026, TO JUNE 6, 2026 AT NO ADDITIONAL COST TO THE GOVERNMENT. ADMINISTRATIVELY THE DFARS CLAUSE 252.204-7021 IS INCORPORATED INTO THE CONTRACT. |
| Nov 3, 2025 | P00014 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0003 FROM DECEMBER 10, 2025, TO MARCH 9, 2026 AT NO ADDITIONAL COST TO THE GOVERNMENT. |
| May 28, 2025 | P00013 | $98.8K | THE PURPOSE OF THIS MODIFICATION IS TO 1) INCREASE THE CEILING AND PROVIDE FUNDING TO CLIN 0004 IN THE AMOUNT OF $98,800 2) UPDATE SECTION C WITH SOW REVISION 2 3) EXTEND THE PERIOD OF PERFORMANCE TO DECEMBER 10, 2025 4) OTHER ADMIN ACTIONS |
| Jan 2, 2025 | P00012 | $150.0K | EQUITABLY INCREASE THE VALUE OF THE CONTRACT BY $150,000 AND INCREASE THE CEILING AS WELL AS FUND CLIN 0004 IN THE AMOUNT OF $150,000. SOW REVISION 1 INCORPORATED. POP EXTENDED TO 10 SEPTEMBER 2025. TPOC CHANGED TO MS. SARAH BRAY. |
| Aug 2, 2024 | P00011 | $401.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO FULLY FUND CLIN 0004/PHASE 4 IN THE AMOUNT OF $400,966, HENCEFORTH THIS CONTRACT IS FULLY FUNDED. THIS MODIFICATION ALSO CHANGES THE DFAS DODAAC FROM HQ0337 TO HQ0338. |
| Mar 28, 2024 | P00010 | $500.0K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 3 / CLIN 0004 AND TO INCREMENTALLY FUND IT IN THE AMOUNT OF $500,000. |
| Apr 6, 2023 | P00009 | $752.3K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO FULLY FUND CLIN 0003/PHASE 3 IN THE AMOUNT OF $752,328.75. HENCEFORTH CLIN 0003 IS FULLY FUNDED. |
| Mar 2, 2023 | P00008 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY DELETE IN ITS ENTIRETY THE ASSOCIATED LINE OF ACCOUNTING UNDER SLIN 000301 AND REPLACE IT WITH THE CORRECT LINE ASSOCIATED WITH PR 1300878801-0008 UNDER NEWLY CREATED SLIN 000302. |
| Feb 22, 2023 | P00007 | $150.5K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 2/CLIN 0003 AND TO INCREMENTALLY FUND IT IN THE AMOUNT OF $150,466.25. THE DELIVERY DATES FOR CLINS 0101 AND 0102 WERE ALSO MODIFIED ACCORDINGLY, IN ORDER TO CORRESPOND WITH THE COMPLETION DATE. |
| Aug 31, 2022 | P00006 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM FEBRUARY 10, 2023, TO APRIL 10, 2023, AT NO ADDITIONAL COST TO THE GOVERNMENT. |
| May 26, 2022 | P00005 | $797.9K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO FULLY FUND CLIN 0002/PHASE 2 IN THE AMOUNT OF $797,878.75. HENCEFORTH CLIN 0002 IS FULLY FUNDED. |
| Mar 15, 2022 | P00004 | $24.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002/PHASE 2 IN THE AMOUNT OF $24,000.00. |
| Jan 31, 2022 | P00003 | $74.7K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 1 / CLIN 0002 AND IT INCREMENTALLY FUND IT. |
| Jun 28, 2021 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ADD MILITARY INTERDEPARTMENTAL PURCHASE REQUEST DETAILS. |
| May 5, 2021 | P00001 | $946.8K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0001/PHASE 1 IN THE AMOUNT OF $946,846.00. HENCEFORTH, CLIN 0001/PHASE 1 IS FULLY FUNDED. |
| Jan 11, 2021 | 0 | $382.5K | BUILT-IN ADAPTIVE SYSTEM TESTING (BAST) |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.